IL-1β breaks tolerance through expansion of CD25+ effector T cells

被引:143
作者
O'Sullivan, Brendan J.
Thomas, Helen E.
Pai, Saparna
Santamaria, Pere
Iwakura, Yoichiro
Steptoe, Raymond J.
Kay, Thomas W. H.
Thomas, Ranjeny
机构
[1] Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Brisbane, Qld 4102, Australia
[2] St Vincents Ctr Med Res, Julia Mcfarlane Diabet Res Ctr, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia
[3] Univ Calgary, Dept Microbiol, Calgary, AB T2N 1N4, Canada
[4] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan
关键词
D O I
10.4049/jimmunol.176.12.7278
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-1 is a key proinflammatory driver of several autoimmune diseases including juvenile inflammatory arthritis, diseases with mutations in the NALP/cryopyrin complex and Crohn's disease, and is genetically or clinically associated with many others. IL-1 is a pleiotropic proinflammatory cytokine; however the mechanisms by which increased IL-1 signaling promotes autoreactive T cell activity are not clear. Here we show that autoimmune-prone NOD and IL-1 receptor antagonist-deficient C57BL/6 mice both produce high levels of IL-1, which drives autoreactive effector cell expansion. IL-1 beta drives proliferation and cytokine production by CD4(+)CD25(+)FoxP3(-) effector/memory T cells, attenuates CD4(+)CD25(+)FoxP3(+) regulatory T cell function, and allows escape of CD4(+)CD25(-) autoreactive effectors from suppression. Thus, inflammation or constitutive overexpression of IL-1 beta in a genetically predisposed host can promote autoreactive effector T cell expansion and function, which attenuates the ability of regulatory T cells to maintain tolerance to self.
引用
收藏
页码:7278 / 7287
页数:10
相关论文
共 53 条
  • [1] Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes
    Achenbach, P
    Koczwara, K
    Knopff, A
    Naserke, H
    Ziegler, AG
    Bonifacio, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (04) : 589 - 597
  • [2] NALP3 forms an IL-lβ-Processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder
    Agostini, L
    Martinon, F
    Burns, K
    McDermott, MF
    Hawkins, PN
    Tschopp, J
    [J]. IMMUNITY, 2004, 20 (03) : 319 - 325
  • [3] Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases
    Alyanakian, MA
    You, S
    Damotte, D
    Gouarin, C
    Esling, A
    Garcia, C
    Havouis, S
    Chatenoud, L
    Bach, JF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) : 15806 - 15811
  • [4] Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
    Andre, I
    Gonzalez, A
    Wang, B
    Katz, J
    Benoist, C
    Mathis, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2260 - 2263
  • [5] Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
    Arif, S
    Tree, TI
    Astill, TP
    Tremble, JM
    Bishop, AJ
    Dayan, CM
    Roep, BO
    Peakman, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (03) : 451 - 463
  • [6] TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
    Belghith, M
    Bluestone, JA
    Barriot, S
    Mégret, J
    Bach, JF
    Chatenoud, L
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1202 - 1208
  • [7] Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells
    Bettelli, E
    Dastrange, M
    Oukka, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (14) : 5138 - 5143
  • [8] Inferences, questions and possibilities in toll-like receptor signalling
    Beutler, B
    [J]. NATURE, 2004, 430 (6996) : 257 - 263
  • [9] BRENNAN FM, 1989, LANCET, V2, P244
  • [10] X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II
    Dessen, A
    Lawrence, CM
    Cupo, S
    Zaller, DM
    Wiley, DC
    [J]. IMMUNITY, 1997, 7 (04) : 473 - 481